oculus innovative sciences i
Transactions by OCULUS INNOVATIVE SCIENCES I (OCLS) in the last 6 months
Pulmatrix, Inc. entered into an agreement and plan of merger to acquire Ruthigen, Inc. (NasdaqCM:RTGN) in a reverse merger transaction on March 13, 2015. As part of consideration, each outstanding share of Pulmatrix common stock will be converted into 0.148187124066461 of one share of Ruthigen common stock. Immediately following the merger, Pulmatrix stockholders are expected to own approximately 81% of the outstanding capital stock of Ruthigen. For a period of twelve ...
Oculus Innovative Sciences, Inc.
Dawson James Securities, Inc.
|Astellas Pharma Inc||¥1,800 JPY||-4.00|
|Henry Schein Inc||$139.40 USD||+0.72|
|Integra LifeSciences Holdings Corp||$60.79 USD||+0.25|
|Patterson Cos Inc||$46.39 USD||+0.45|
|Smith & Nephew PLC||1,163 GBp||+29.00|
|View Industry Companies|
|Price/Cash Flow||NM||Not Meaningful|